MORELLI, Catia
 Distribuzione geografica
Continente #
NA - Nord America 2.698
EU - Europa 1.724
AS - Asia 775
AF - Africa 84
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 7
Totale 5.312
Nazione #
US - Stati Uniti d'America 2.649
UA - Ucraina 507
IT - Italia 360
DE - Germania 346
CN - Cina 326
SG - Singapore 293
AT - Austria 190
SE - Svezia 160
SN - Senegal 82
TR - Turchia 68
FI - Finlandia 43
CA - Canada 40
IN - India 38
FR - Francia 34
CZ - Repubblica Ceca 22
HK - Hong Kong 18
KR - Corea 17
BE - Belgio 14
GB - Regno Unito 14
BR - Brasile 9
MX - Messico 8
AU - Australia 7
EU - Europa 7
ES - Italia 6
RU - Federazione Russa 6
IR - Iran 5
NL - Olanda 5
AR - Argentina 3
CH - Svizzera 3
CL - Cile 3
EE - Estonia 3
LT - Lituania 3
DK - Danimarca 2
EC - Ecuador 2
ID - Indonesia 2
IE - Irlanda 2
AZ - Azerbaigian 1
CY - Cipro 1
EG - Egitto 1
GE - Georgia 1
JP - Giappone 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LV - Lettonia 1
PA - Panama 1
PK - Pakistan 1
PL - Polonia 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 5.312
Città #
Chandler 436
Jacksonville 301
Boardman 262
Singapore 230
San Mateo 205
Dearborn 154
New York 142
Ashburn 115
Vienna 110
Rende 103
Shanghai 85
Dakar 82
Roxbury 82
Lawrence 81
Izmir 56
Des Moines 53
Grafing 44
Helsinki 41
Bremen 38
Brooklyn 36
Wilmington 35
Beijing 32
Cosenza 31
Ottawa 31
Ogden 28
Inglewood 26
Cambridge 23
Florence 22
Guangzhou 21
Los Angeles 21
Ann Arbor 20
Pune 20
Seattle 17
Seoul 17
Hong Kong 16
Redwood City 15
Brussels 14
Wuhan 13
Falls Church 12
Munich 12
Brno 11
Olomouc 11
Jinhua 10
San Francisco 9
Toronto 9
Bari 7
Hanover 7
Taranto 7
Washington 7
Wuxi 7
Hefei 6
Castrovillari 5
Cinquefrondi 5
Curtarolo 5
Hangzhou 5
Jiaxing 5
Nanjing 5
Naples 5
Reggio Calabria 5
Catanzaro 4
Conversano 4
Heze 4
Milan 4
Ningbo 4
Shenyang 4
Adelaide 3
Amantea 3
Augusta 3
Avetrana 3
Belvedere Marittimo 3
Changsha 3
Fano 3
Jacurso 3
Jinan 3
Kilburn 3
Kunming 3
Livorno 3
London 3
Mountain View 3
Paris 3
Prineville 3
Quanzhou 3
Redmond 3
Santa Clara 3
Tallinn 3
Tampa 3
Torino 3
Valencia 3
Vicenza 3
Antalya 2
Ardabil 2
Bagnara Calabra 2
Bangalore 2
Berlin 2
Bianco 2
Canberra 2
Casavatore 2
Castrolibero 2
Chennai 2
Chicago 2
Totale 3.331
Nome #
Bortezomib-Based Delivery System 130
Akt2 inhibition enables the forkhead transcription factor FoxO3 to a repressive role for ERalpha transcriptional activity in breast cancer cells 116
Bortezomib-loaded mesoporous silica nanoparticles selectively alter metabolism and induce death in multiple myeloma cells 112
Androgens inhibit aromatase expression through DAX-1: disclosing the molecular link between hormone balance and leydig cancer development. 106
Bergapten drives autophagy through the up-regulation of PTEN expression in breast cancer cells. 102
Androgen receptor regulation of the cyclin D1 gene through an androgen response element in the proximal promoter 98
Adherence to the Mediterranean diet pattern among university staff: a cross-sectional web-based epidemiological study in Southern Italy 98
Androgen Receptor (AR) Inhibits Cyclin D1 Promoter Activity. May AR be Considered as na Oncosuppressor in Breast Cancer? 97
17β-estradiol enhances α(5) integrin subunit gene expression through ERα-Sp1 interaction and reduces cell motility and invasion of ERα-positive breast cancer cells 97
Valproic acid addresses neuroendocrine differentiation of LNCaP cells and maintains cell survival 97
DAX-1, as an androgen-target gene, inhibits aromatase expression: A novel mechanism blocking estrogendependent breast cancer cell proliferation 93
Androgens inhibit aromatase expression through DAX-1: insights into the molecular link between hormone balance and Leydig cancer development 92
Estradiol via estrogen receptor beta influences ROS levels through the transcriptional regulation of SIRT3 in human seminoma TCam-2 cells.doi: 10.1177/1010428317701642.PMID: 28459202 92
Anticancer Activity of a Quercetin-based Polymer Towards HeLa Cancer Cells 91
AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells 90
Impact of Vigorous-Intensity Physical Activity on Body Composition Parameters, Lipid Profile Markers, and Irisin Levels in Adolescents: A Cross-Sectional Study. 87
Dealing with skin and blood-brain barriers: The unconventional challenges of mesoporous silica nanoparticles 83
ENGINEERED MESOPOROUS SILICA-BASED NANOPARTICLES AS SMART CHEMOTHERAPY FOR BORTEZOMIB ADMINISTRATION 81
AR/ER coactivator squelcing contributes to the inhibition of estrogen-dependent cyclin D1 expression in breast cancer 79
Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells 79
FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer 79
Controlled release of 5-FU from Chi-DHA nanoparticles synthetized with ionic gelation technique: Evaluation of release profile kinetics and cytotoxicity effect. 79
Evidence that low doses of taxol enhance the functional transactivatory properties of p53 on p21 waf promoter in MCF-7 breast cancer cells 78
Cisplatin-Loaded Folic Acid Functionalized Mesoporous Silica Selectively Enters and Kills Folate Receptor Expressing Cancer Cells 76
Controlled release of sunitinib in targeted cancer therapy: smart magnetically responsive hydrogels as restricted access materials 75
A novel interplay between AR and DAX-1 controls aromatase expression in estrogen-dependent cancers 74
SISTEMA DI RILASCIO A BASE DI BORTEZOMIB 74
Akt2 inhibition enables the forkhead transcription factor FoxO3a to have a repressive role in estrogen receptor α transcriptional activity in breast cancer cells 73
Mesoporous silica-based hybrid materials for bone-specific drug delivery 73
DAX-1 at the Crossroads Between Androgens and Aromatase: A Novel Mechanism in the Inhibition of Estrogen-Dependent Cancer Cell Proliferation 71
Evidence for enhanced exosome production in aromatase inhibitor-resistant breast cancer cells 71
Cisplatin-loaded, Folic Acid Functionalized Mesoporous Silica-based Nanovehicles Kills Folate receptor Expressing Cancer Cells 68
FoxO3a mediates the inhibitory effects of the antiepileptic drug Lamotrigine on breast cancer growth 67
Chenodeoxycholic acid through a TGR5-dependent CREB-signaling activation enhances Cyclin D1 expression and promotes human endometrial cancer cell proliferation 67
Foxo3a re-expression overcomes tamoxifen resistance in breast cancer 66
Impact of Mediterranean Diet Food Choices and Physical Activity on Serum Metabolic Profile in Healthy Adolescents: Findings from the DIMENU Project 65
PEG-templated mesoporous silica nanoparticles exclusively target cancer cells 64
Potential antioxidant and anti-inflammatory properties of serum from healthy adolescents with optimal mediterranean diet adherence: findings from DIMENU cross-sectional study 63
Nuclear insulin receptor substrate 1 interacts with estrogen receptor alpha at ERE promoters 62
Evidence that the mouse insulin receptor substrate-1 belongs to the gene family on which the promoter is activated by estrogen receptor alpha through its interaction with Sp1 62
Modulating Tumor-Associated Macrophage polarization by synthetic and natural PPARγ ligands as a potential target in breast cancer 62
Nutrition Education Program and Physical Activity Improve the Adherence to the Mediterranean Diet: Impact on Inflammatory Biomarker Levels in Healthy Adolescents From the DIMENU Longitudinal Study 62
Interaction between estrogen receptor alpha and insulin/IGF signaling in breast cancer 60
Mesoporous Silica Nanoparticles in Cancer Therapy: Relevance of the Targeting Function 59
Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element 59
The antiepileptic drug Lamotrigine, through FoxO3a, inhibits breast cancer growth and development both in vitro and in vivo. Pellegrino M, Rizza P, Giordano F, Spina E, Ceraldi R, Andò S, Morelli C, Sisci D. 51
Role of the IGF-I receptor in the regulation of cell-cell adhesion. Implications in cancer development and progression 50
The modulatory role of IRS-1 on cell adhesion in human breast cancer cells 49
Insulin receptor substrate 1 modulates the transcriptional activity and the stability of androgen receptor in breast cancer cells 48
Red wine consumption may affect sperm biology: The effects of different concentrations of the phytoestrogen Myricetin on human male gamete function 48
Up-regulation of p53 gene expression by PPARgamma in human MCF-7 breast cancer cells 47
Nanosistemi di silice mesoporosa ibrida per il direzionamento selettivo di farmaci antitumorali. 47
Peroxisome proliferator-activated receptor-gamma activates p53 gene promoter binding to the nuclear factor-kappaB sequence in human MCF7 breast cancer cells 47
Foxo3a inhibits tamoxifen-resistant breast cancer progression by inducing integrin α5 expression 47
Magnetic molecularly imprinted polymers (MMIPs) for carbazole derivative release in targeted cancer therapy 46
Expression of nuclear insulin receptor substrate 1 (IRS-1) in breast cancer 44
Function of the Insulin-Like Growth Factor Receptor I in metastatic breast cancer cells 44
Nuclear IRS-1 as a novel marker for breast cancer progression 44
Production of Plant-Derived Oleuropein Aglycone by a Combined Membrane Process and Evaluation of Its Breast Anticancer Properties 44
LPL, FNDC5 and PPARγ gene polymorphisms related to body composition parameters and lipid metabolic profile in adolescents from Southern Italy 44
Leptin secretion by human ejaculated spermatozoa 43
Hybrid Mesoporous Silica: A Preliminary Attempt to Engineer a drug Targeting Device 43
The mechanism of IGF-I receptor-induced cell-cell adhesion of MCF-7 breast cancer cells 43
Human Sperm Anatomy: Different Expression and Localization of Phosphatidylinositol 3-Kinase in Normal and Varicocele Human Spermatozoa 43
Functional crosstalk between Peroxisome Proliferator-Activated Receptor gamma and p53 tumor suppressor gene in MCF-7 breast cancer cells 40
Insuline-like Growth Factor I Receptor (IGF-IR) signaling in metastatic breast cancer cells 40
The estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness. DOI: 10.4161/cc.26421, WOS:000327381000012 ;2-s2.0-84887977769;PMID: 24047697 40
First evidence of the up-regulatory effect of androgen on DAX-1 gene expression : is this a novel mechanism for inhibiting breast cancer cell proliferation? 39
The estrogen receptor alpha:insulin receptor substrate 1 complex in breast cancer: structure-function relationships 39
Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells: identification of a novel androgen response element. 38
FoxO3a transcription factor differentially modulates the metastatic potential of ER+ and ER- breast tumors 38
A Mesoporous silica-based Nanodevice as a vehicle for Specific Drug Targeting and Improved Efficacy in the treatment of Multiple Myeloma. 37
Function of the insulin-like growth factor I receptor in metastatic breast cancer cells 37
First evidence of the up-regulatory effects of androgens on DAX-1 gene expression: is this a novel mechanism for inhibiting breast cancer cell proliferation? 37
Insulin receptor substrate 1 modulates the transcriptional activity and the stability of androgen receptor in breast cancer cells 37
Effetti delle basse dosi di tassolo sull’espressione di alcune proteine segnali che anticipano il blocco mitotico nella linea cellulare di tumore mammario MCF-7 35
Insulin receptor substrate 1 modulates the transcriptional activity and turnover of androgen receptor in breast cancer cells 34
Regulation of ER mediated transcription by akt2/foxo3a signalling in breast cancer cells 34
Insulin receptor substrate 1 (IRS-1) a target of hormonal regulation in breast cancer cells 33
The other side of the coin: May androgens have a role in breast cancer risk? 31
The Omega-3 Docosahexaenoyl Ethanolamide Reduces CCL5 Secretion in Triple Negative Breast Cancer Cells Affecting Tumor Progression and Macrophage Recruitment 29
Preparation and cell inclusion of fluorescent folic acid- functionalizedmesoporous silica microspheres potentially useful for drug targeting 29
Serum from Adolescents with High Polyphenol Intake Exhibits Improved Lipid Profile and Prevents Lipid Accumulation in HepG2 Human Liver Cells 25
Androgens Modulate Bcl-2 Agonist of Cell Death (BAD) Expression and Function in Breast Cancer Cells 21
Complete engineering of the administration of a drug: mesoporous silica-based nanodevices for smart chemotherapy 20
Retinoic acid mediates degradation of IRS-1 by the ubiquitin-proteasome pathway, via a PKC-dependant mechanism 19
Estrogen receptor-α regulates the degradation of insulin receptor substrates 1 and 2 in breast cancer cells 19
Peptides Targeting HER2-Positive Breast Cancer Cells and Applications in Tumor Imaging and Delivery of Chemotherapeutics 18
NEW APPROACH FOR THE DELIVERY OF ANTINEOPLASTIC DRUG: MESOPOROUS SILICA NANOPARTICLES AND BORTEZOMIB IN MICE MODEL 18
Leptin expression in breast nipple aspirate fluid (NAF) and serum is influenced by body mass index (BMI) but not by the presence of breast cancer 18
Mesoporous silica-based nanodevice for targeted cancer therapy 17
Engineered Mesoporous Silica-Based Nanoparticles: Characterization of Surface Properties 17
Hybrid Mesoporous Silica for Drug Targeting 17
FoxO3a Drives the Metabolic Reprogramming in Tamoxifen-Resistant Breast Cancer Cells Restoring Tamoxifen Sensitivity 15
Nanostructured Mesoporous Silica-Based Devices for Smart Chemotherapy 14
Hybrid Polymer-Silica Nanostructured Materials for Environmental Remediation 14
Engineered nanoparticles for targeted delivery of the anticancer drug Bortezomib 12
From HDAC to Voltage-Gated Ion Channels: What's Next? The Long Road of Antiepileptic Drugs Repositioning in Cancer 10
Mesoporous silica-based nanocarrier for targeted cancer therapy 10
Impact of COVID-19 Lockdown on Metabolic/Inflammatory Profile in Adolescents: Cellular Studies and Predictive Biomarkers 9
Totale 5.441
Categoria #
all - tutte 40.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.930


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020467 0 0 0 0 40 158 47 95 23 9 69 26
2020/2021603 72 1 66 72 8 77 11 83 69 71 17 56
2021/20221.088 3 134 15 66 141 56 16 232 20 9 139 257
2022/20231.218 172 154 34 123 161 103 30 152 136 43 63 47
2023/2024963 85 45 56 28 45 252 48 29 85 46 29 215
2024/2025682 147 246 62 124 103 0 0 0 0 0 0 0
Totale 5.452